Original Research
| Abstract Title: Abstract #: Location: Date & Time: Session Title: Presenter: | Bempedoic Acid In Children Aged 6-17 Years With Heterozygous Familial Hypercholesterolaemia: A Phase 2 Study 178 Station 08 May 25, 2026; 7:35-8:35 AM EST Science-at-a-Glance (SaaG) Session: Real-World Lipid-Lowering Therapies and Determinants of Treatment Success Samuel S Gidding, MD |
| Abstract Title: Abstract #: Location: Date & Time: Session Title: Presenter: | Factors Associated With Enhanced LDL-Cholesterol Lowering With Bempedoic Acid Among Statin-Intolerant Patients From CLEAR Outcomes 338 Station 08 May 25, 2026; 7:35-8:35 AM EST SaaG Session: Real-World Lipid-Lowering Therapies and Determinants of Treatment Success Christie M Ballantyne, MD |
Encore Presentations
| Abstract Title: Session ID: Location: Date & Time: Session Title: Presenter: | The Association Between Bempedoic Acid And Risk Of Venous Thromboembolism: A Post Hoc Analysis Of The CLEAR Outcomes Trial 122 Elisaf Hall May 25, 2026; 3:30-5:00 AM EST New perspectives on lipid lowering therapies Prof. Stephen J Nicholls, MBBS, PhD |
| Abstract Title: Abstract #: Location Date & Time: Session Title: Presenter: | Bempedoic Acid And Incidence Of Stroke Among Statin- Intolerant Patients: An Analysis Of The CLEAR Outcomes Trial 481 Station 07 May 25, 2026; 6:30-7:30 AM EST SaaG Session: Novel Lipid-Lowering Therapies: Clinical Outcomes and Real-World Evidence Prof. Stephen J Nicholls, MBBS, PhD |
| Abstract Title: Abstract #: Location Date & Time: Session Title: Presenter: | Bempedoic Acid Without Background LLT, LDL Cholesterol And Cardiovascular Events: A Secondary Analysis Of The CLEAR Outcomes Trial 455 Station 07 May 25, 2026; 6:30-7:30 AM EST SaaG Session: Novel Lipid-Lowering Therapies: Clinical Outcomes and Real-World Evidence Prof. Kausik K Ray, MD |
Login to comment